+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopsy Devices Market Research and Forecast, 2022-2028

  • Report
  • 135 Pages
  • July 2022
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 3821042

Global Biopsy Devices Market by Type (Needle-based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Biopsy Guidance Systems), By Therapeutics (Breast Biopsy, Prostate Biopsy, Lung Biopsy, Colorectal Biopsy, and Others), and Forecast Period 2022-2028

The global biopsy devices market is anticipated to grow at a CAGR of over 6.0% during the forecast period. The major factors driving the growth of the market include the increasing number of cancer cases coupled with the growing demand for minimally invasive surgeries. Further, the rising initiatives from the government as well as health organizations to spread awareness regarding cancer across the globe are expected to be a crucial driver for future market growth.

Moreover, a boost in demand for disposable biopsy devices, rising expenditure on healthcare infrastructure in developing economies, growing geriatric population, and the introduction of cost-effective biopsy devices are also expected to propel the demand for biopsy devices, which in turn will create ample growth opportunity for market players.

Segmental Outlook

The global biopsy devices market is segmented on the basis of type and therapeutics. By type, the market is segmented into needle-based biopsy guns (vacuum-assisted biopsy devices, core needle biopsy devices, fine needle aspiration biopsy devices), biopsy needles (disposable biopsy needles, reusable biopsy needles), biopsy forceps (cold biopsy forceps, hot biopsy forceps), and biopsy guidance systems (manual guidance systems, robotic guidance systems). Further, based on the therapeutics segment, the market is segmented into breast biopsy, prostate biopsy, colorectal biopsy, lung biopsy, and others.

Needle-based biopsy guns are estimated to contribute a prominent share in the global market. The increasing demand for these guns to acquire samples from soft tissues of internal organs such as breasts, and lungs tend to drive the segmental growth of the market during the forecast horizon. Moreover, the increasing need for rapid and gentle procurement of cell samples for biopsy is another major factor to drive the segmental growth of the market.

Regional Outlooks

Geographically, the study of the global biopsy devices market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, India, Japan, and the Rest of Asia-Pacific) and the Rest of the World (Latin America and the Middle East & Africa). North America is estimated to contribute a prominent share to the global adipic acid market. The increasing number of cancer cases is one of the major factors driving the growth of the market in the region. Asia-Pacific is estimated to be the fastest-growing region during the forecast period.

Global Biopsy Devices Market Growth by Region, 2022-2028

Global Biopsy Devices Market Growth by Region

Asia-Pacific to Exhibit Considerable Growth in the Global Biopsy Devices Market

Asia-Pacific is expected to create an ample opportunity for the global biopsy devices market. The regional market is driven by the increasing number of diagnosed patients, improving healthcare infrastructure, and increasing spending by the government in the healthcare sector. Further, the increasing base of the geriatric population coupled with the surging prevalence of cancer in the region also creates demand for biopsy devices and hence drives the regional growth of the market.

Market Players Outlook

Further, the report covers the analysis of various players operating in the market. Some of the key players covered in the report include Becton, Dickinson and Co., Hologic Inc., Boston Scientific Corp., Koninklijke Philips NV, Inivata Ltd., and others. In order to survive in the market, these players adopt different marketing strategies such as mergers, acquisitions, product launches, and geographical expansion. For instance, in August 2020, Hologic, Inc. launched a breast biopsy solution that combined vacuum-assisted tissue along with imaging verification in real-time and advanced post-biopsy handling.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global biopsy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

Table of Contents

1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Vocal Biomarker Industry
  • Recovery Scenario of Global Vocal Biomarker Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Vocal Biomarker Market by Application
5.1.1. Psychological Disorders
5.1.2. Neurological Disorders
5.1.3. Respiratory Disorders
5.1.4. Cardiovascular Disease
5.2. Global Vocal Biomarker Market by End-User
5.2.1. Hospitals
5.2.2. Diagnostic Centre
5.2.3. Academics Research Institute
5.3. Global Vocal Biomarker Market by Type
5.3.1. Frequency
5.3.2. Amplitude
5.3.3. Error Rate
5.3.4. Vocal Rise or Fall Time
5.3.5. Phonation Time
5.3.6. Other (Voice Tremor, Pitch)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Boston Technology Corp.
7.2. Cogito Corp.
7.3. conversation HEALTH Group
7.4. IBM Corp.
7.5. Mayo Clinic Inc.
7.6. Medical Information Technology, Inc.
7.7. MediTECH Electronic GmbH
7.8. Orbita Inc.
7.9. PureTech Health Plc
7.10. Sonde Health, Inc.
7.11. Vocalis Health, Inc.
7.12. Winterlight Labs Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Argon Medical Devices Inc.
  • Becton, Dickinson and Co.
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • Cook Group Inc.
  • Creganna Medical
  • Cynvenio Biosystems, Inc.
  • DilonMedical Technologies Inc
  • DTR Medical Ltd.
  • Ethicon Inc. (Johnson & Johnson Services Inc.)
  • Hologic Inc.
  • Inivata Ltd.
  • Integra LifeSciences Corp.
  • Koninklijke Philips N.V.
  • MDxHealth SA
  • Medtronic Plc
  • Remington Medical Inc.
  • Scion Medical Technologies, LLC
  • Seno Medical Instruments, Inc.
  • Stryker Corp.